By IDSE News Staff
The FDA reminded practitioners about the side effects of hydroxychloroquine and chloroquine, including potentially life-threatening arrhythmias and asked providers to report any adverse event to the FDA MedWatch system.
There have been several adverse events reported with the use of these medications for the prevention and treatment of COVID-19, which is an off-label use, the agency said.